Business
Why the Alterity (ASX:ATH) share price is skyrocketing 42% today
One of the best performers on the ASX today is the Alterity Therapeutics Ltd (ASX: ATH) share price. Driving the meteoric rise, the biotech company announced positive results for its lead compound, ATH434.
At the time of writing, Alterity shares are swapping hands for 4.25 cents apiece, up 41.67%.
What does Alterity do?
Alterity is an Australian biotech company focused on commercialising research into neurodegenerative disorders. These include Parkinsonian movement disorders, Alzheimer’s disease, Huntington disease and others.
The company’s lead candidate ATH434 is currently in development. It aims to block the aggregation of pathological proteins that cause brain degeneration. Current remedies include medications and lifestyle…
-
General20 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General22 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
Business22 hours agoTop brokers name 3 ASX shares to buy next week 12 October 2025
-
Noosa News18 hours agoSerious traffic crash, Noosa – Sunshine Coast